Find uplifting stories about heroes, innovations, and solutions
11 results for "vaccine trial"
Scientists in the UK and US have started testing a new bird flu vaccine on 4,000 people, taking a proactive step to prepare for potential future pandemics. The vaccine uses the same mRNA technology that proved successful with COVID-19 shots.
Scientists in South Africa are leading a breakthrough tuberculosis vaccine trial that could protect adolescents and adults for the first time in over a century. The M72 vaccine, combined with faster tests and shorter treatments, marks a turning point against the world's deadliest infectious disease.
After a century with only one TB vaccine, three promising candidates are in final trials, led by South African researchers who could deliver a breakthrough by 2028. The new vaccines could prevent millions of deaths from a disease that still kills over 1.5 million people yearly.
Britain just launched a groundbreaking 24-week trial to vaccinate turkeys against bird flu, a disease that's cost the government and poultry industry up to £174 million annually. This marks a major shift in strategy that could protect food supplies and prevent devastating flock losses.
%2Ffile%2Fattachments%2Forphans%2F2HIVVaccineResearch_437240.jpg)
When the US pulled funding for a groundbreaking HIV vaccine trial in Cape Town, South African scientists refused to quit. They found new backers and launched a scaled-down version that could reinvigorate global vaccine research.
A groundbreaking HIV vaccine study in Cape Town is moving forward after South African researchers regrouped when US funding vanished. The trial tests a novel approach that could finally unlock the key to preventing HIV.
South Africa just enrolled its first participant in a groundbreaking HIV vaccine trial designed specifically for African strains of the virus. This time, African scientists are leading the charge.
Scientists in South Africa are launching three groundbreaking medical advances that could save thousands of lives across Africa and beyond. The projects include an HIV vaccine trial, the first potential preeclampsia treatment, and Africa-focused drug development.
Every woman from a small 2000s breast cancer vaccine trial is alive today, decades past typical survival odds. Scientists now know why their immune systems stayed cancer-ready for 20 years.
A woman's dog detected her breast cancer by pressing his nose to a lump on her chest. Now she's part of a groundbreaking vaccine trial that could prevent aggressive breast cancer from returning.
A major review of vaccine trials reveals that care home residents, despite being most vulnerable to infections, have been systematically excluded from the very trials testing vaccines designed for them. Scientists are now calling for mandatory inclusion to ensure safety and effectiveness for this at-risk population.